文献速递乳房整形与再造美容整形

评估S-PECS阻滞在乳房增大手术中的疗效:一项随机双盲对照试验

Assessing the Efficacy of the S-PECS Block in Breast Augmentation Surgery: A Randomized, Double-Blind, Controlled Trial.
PubMed 文献 · Plast Reconstr Surg · 2023-04-04

该单中心随机双盲对照试验纳入30例接受硅胶假体乳房增大手术的女性患者,分为PECS组和no-PECS对照组各15例,评估S-PECS阻滞的镇痛效果。结果显示PECS组在复苏时及术后4、6、12小时疼痛评分均显著低于no-PECS组,且PECS组请求镇痛药物的可能性较no-PECS组降低74%(P<0.05)。

要点

  • S-PECS阻滞组在复苏时及术后4、6、12小时疼痛评分均显著低于no-PECS组。
  • 接受S-PECS阻滞的患者请求镇痛药物的可能性较no-PECS组降低74%(P<0.05)。
  • 作者认为改良S-PECS阻滞是控制乳房增大手术疼痛的有效、高效且安全的方法。

核心结论

  • 改良S-PECS阻滞是控制乳房增大手术患者疼痛的有效、高效且安全的方法,其他应用尚待探索。

研究设计与样本

  • 单中心、随机、对照、双盲分组试验,纳入30例接受硅胶乳房假体增大手术并接受S-PECS阻滞的女性患者,分为PECS组15例和no-PECS对照组15例。
  • PECS组接受局部麻醉药注射,no-PECS对照组接受生理盐水注射。
  • 所有参与者在复苏时及术后4、6、12小时接受随访。

主要发现

  • PECS组在复苏时及术后4、6、12小时所有时间点的疼痛评分均显著低于no-PECS组。
  • 接受S-PECS阻滞的患者请求镇痛药物的可能性较no-PECS组降低74%(P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative acute and chronic pain following breast surgery is a common complication that needs resolving to allow for improved patient outcomes. Previously, thoracic epidurals and paravertebral blocks have been the accepted standard administered intraoperatively. However, more recently the introduction of the pectoral nerve block (PECS and PECS-2 blocks) has appeared promising to control the pain more effectively, but further robust analysis is required to prove its efficacy. The authors aim to study the efficacy of a new block, S-PECS, that combines a serratus anterior and a PECS-2 block. METHODS: In this study, the authors performed a single-center, randomized, controlled, double-blind group trial in 30 female patients undergoing breast augmentation surgery with silicone breast implants and the S-PECS block. Divided into two groups of 15, the PECS group received local anesthetics and the no-PECS control group received a saline injection. All participants were followed up at recovery and at 4, 6, and 12 hours postoperatively. RESULTS: The authors' results showed that the pain score in the PECS group was significantly less than in the no-PECS group across all time points: recovery, and at 4, 6, and 12 hours. Furthermore, the patients who received the S-PEC block were 74% less likely to request pain medications compared with the no-PECS group ( P < 0.05). CONCLUSION: Overall, the modified S-PECS block is an effective, efficient, and safe method of controlling pain in patients undergoing breast augmentation surgery, with additional applications yet to be explored.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sforza M, Saghir R, Saghir N, et al. Assessing the Efficacy of the S-PECS Block in Breast Augmentation Surgery: A Randomized, Double-Blind, Controlled Trial. Plast Reconstr Surg. 2023. PMID: 37010475. doi:10.1097/PRS.0000000000010492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。